Evidence map›Paper›PMID 31138110›Full record

ArticleBMC genomics2019

Transposon libraries identify novel Mycobacterium bovis BCG genes involved in the dynamic interactions required for BCG to persist during in vivo passage in cattle.

Tom A Mendum, Aneesh Chandran, Kerstin Williams, H Martin Vordermeier, Bernardo Villarreal-Ramos, H Wu, Albel Singh, Alex A Smith, Rachel E Butler, Aravind Prasad and 6 more

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Journal of bacteriology · 2026
    Article
  2. Review
  3. Article
  4. Loss ofbioRxiv : the preprint server for biology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Molecular Mechanisms of MmpL3 Function and Inhibition.Microbial drug resistance (Larchmont, N.Y.) · 2023
    Review
  9. Article
  10. Article
  11. The Indian journal of medical research · 2022
    Review
  12. Article
  13. Article
  14. Quantification ofProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Tom A MendumSchool of Biosciences and Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford, GU2 7XH, UK.ORCID http://orcid.org/0000-0002-6331-2605
Aneesh ChandranSchool of Biosciences and Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford, GU2 7XH, UK.
Kerstin WilliamsSchool of Biosciences and Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford, GU2 7XH, UK.
H Martin VordermeierDepartment of Bacteriology, Animal and Plant Health Agency, Weybridge, UK.
Bernardo Villarreal-RamosDepartment of Bacteriology, Animal and Plant Health Agency, Weybridge, UK.
H WuSchool of Biosciences and Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford, GU2 7XH, UK.
Albel SinghInstitute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, Birmingham, UK.
Alex A SmithSchool of Biosciences and Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford, GU2 7XH, UK.
Rachel E ButlerSchool of Biosciences and Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford, GU2 7XH, UK.
Aravind PrasadHPC-Medical and Bioinformatics Applications Group, Centre for Development of Advanced Computing, Innovation Park, Panchavati, Pashan, Pune, Maharashtra, 411008, India.
Neeraj BhartiHPC-Medical and Bioinformatics Applications Group, Centre for Development of Advanced Computing, Innovation Park, Panchavati, Pashan, Pune, Maharashtra, 411008, India.
Ruma BanerjeeHPC-Medical and Bioinformatics Applications Group, Centre for Development of Advanced Computing, Innovation Park, Panchavati, Pashan, Pune, Maharashtra, 411008, India.
Sunitha M KasibhatlaHPC-Medical and Bioinformatics Applications Group, Centre for Development of Advanced Computing, Innovation Park, Panchavati, Pashan, Pune, Maharashtra, 411008, India.
Apoorva BhattInstitute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, Birmingham, UK.
Graham R StewartSchool of Biosciences and Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford, GU2 7XH, UK.
Johnjoe McFaddenSchool of Biosciences and Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford, GU2 7XH, UK. j.mcfadden@surrey.ac.uk.
University of Surrey · GBCentre for Development of Advanced Computing · INAnimal and Plant Health Agency · GBUniversity of Birmingham · GB

Funding

Bill and Melinda Gates Foundation 03011000075Biotechnology and Biological Sciences Research Council (GB) BB/L024209/1National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/M002012/1
6 · The paper itself

Abstract

backgroundBCG is the most widely used vaccine of all time and remains the only licensed vaccine for use against tuberculosis in humans. BCG also protects other species such as cattle against tuberculosis, but due to its incompatibility with current tuberculin testing regimens remains unlicensed. BCG's efficacy relates to its ability to persist in the host for weeks, months or even years after vaccination. It is unclear to what degree this ability to resist the host's immune system is maintained by a dynamic interaction between the vaccine strain and its host as is the case for pathogenic mycobacteria.

resultsTo investigate this question, we constructed transposon mutant libraries in both BCG Pasteur and BCG Danish strains and inoculated them into bovine lymph nodes. Cattle are well suited to such an assay, as they are naturally susceptible to tuberculosis and are one of the few animal species for which a BCG vaccination program has been proposed. After three weeks, the BCG were recovered and the input and output libraries compared to identify mutants with in vivo fitness defects. Less than 10% of the mutated genes were identified as affecting in vivo fitness, they included genes encoding known mycobacterial virulence functions such as mycobactin synthesis, sugar transport, reductive sulphate assimilation, PDIM synthesis and cholesterol metabolism. Many other attenuating genes had not previously been recognised as having a virulence phenotype. To test these genes, we generated and characterised three knockout mutants that were predicted by transposon mutagenesis to be attenuating in vivo: pyruvate carboxylase, a hypothetical protein (BCG_1063), and a putative cyclopropane-fatty-acyl-phospholipid synthase. The knockout strains survived as well as wild type during in vitro culture and in bovine macrophages, yet demonstrated marked attenuation during passage in bovine lymph nodes confirming that they were indeed involved in persistence of BCG in the host.

conclusionThese data show that BCG is far from passive during its interaction with the host, rather it continues to employ its remaining virulence factors, to interact with the host's innate immune system to allow it to persist, a property that is important for its protective efficacy.

Indexed as

DNA Transposable ElementsAnimalsBCG VaccineCattleCholesterolGene LibraryGenes, BacterialGenetic FitnessMycobacterium bovisOxazolesSugarsSulfatesTuberculosis, BovineBCG VaccineCholesterolDNA Transposable ElementsmycobactinsOxazolesSugarsSulfatesCattleCyclopropane-fatty-acyl-phospholipid synthaseMycobacterium bovis BCGMycobacterium tuberculosisPyruvate carboxylaseRv1006Transposon library

Identifiers

PMID31138110
PMCPMC6540422
OpenAlexW2947737709

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.